EFTA02642995.pdf

The document discusses the integration of discovery platforms for biotherapeutics and drug reformulation, focusing on diseases caused by oxidative stress. It mentions Geoffrey Ling as a potential scientific cofounder and references Yumanity Therapeutics' vision. The sender suggests adopting a similar approach but proposes ideas inspired by plant disease management.